Best practice example: Control of Anticoagulation effect

Mrs Birgit Blum had an unfortunate fall while skiing and sustained a open tibial plateau fracture. She was transferred to the Kantonsspital, a centre hospital, by helicopter and is waiting there for her operation. The patient is administered Liquemin 5000 E s.c. daily to prevent thromboembolic events, and the effect. To monitor the effect of this treatment, regular blood tests are carried out to determine anti-Xa activity. A special sample vessel with citrate additive is used for this purpose. The sample must be centrifuged and cooled within one hour.